CytoDyn Reports Strong Positive Preclinical Data to Demonstrate Potential of Leronlimab in Treating Nonalcoholic Fatty Liver Disease (NAFLD) in Humanized Mouse Model

Stock Information for CytoDyn Inc

Loading

Please wait while we load your information from QuoteMedia.